ArticleCurrent medical imaging2025
Different Neuroimaging Measurement Techniques for the Cerebellum in Alzheimer's Disease: VolBrain-Horos Comparison.
Article in Current medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe use of magnetic resonance imaging (MRI), which has greater soft tissue contrast than other imaging modalities, has increased over the last 30 years. Studies have shown that MRI is frequently used for diagnosing neurodegenerative diseases. The incidence of Alzheimer's disease, a neurodegenerative condition, is increasing due to population aging and has a detrimental impact on quality of life. Volumetric changes in many important anatomical structures have been detected in magnetic resonance (MR) images of Alzheimer's disease patients. Various software programs, such as OsiriX, Horos, and VolBrain, are currently used to perform area and volume measurements in various brain structures. In this study, we compared the VolBrain and Horos applications for volume measurements of the cerebellum, whose relationship with Alzheimer's disease is not yet fully understood. We aimed to assess the consistency between the applications using various statistical methods and to highlight their respective advantages and disadvantages for researchers.
methodsThis was a retrospective study. The patient group comprised 50 individuals with Alzheimer's disease aged 30-65 years. T1 MR images of 50 Alzheimer's disease patients were first acquired via the VolBrain program and then via the Horos program.
resultsThe applications used yielded almost identical measurement results, and no significant differences were observed. DISCUSSION: Both applications have been found to produce consistent results. This indicates that the methods are reliable and that either application can be effectively used for the intended purpose.
conclusionIn conclusion, the choice between the two applications depends largely on the user's data requirements, software preferences, and hardware capabilities. These factors play a decisive role in the selection process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.